Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5944715 | 7048341 | F | 1 | 5944715-2 | 20071004 | 20081028 | 20081105 | EXP | 2008JP003119 | ASTELLAS PHARMA US, INC. | 13 | YR | F | N | 32 | KG | 20081031 | MD | JAPAN |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5944715 | 1010673182 | PS | FUNGUARD(MICAFUNGIN INJECTION) FUNGUARD(MICAFUNGIN) INJECTION | 2 | INTRAVENOUS | SEE IMAGE | Y | D | 50709 | ||
| 5944715 | 1010711611 | SS | PROGRAF | 1 | INTRAVENOUS | IV NOS | D | D | |||
| 5944715 | 1010711612 | SS | PROGRAF | 1 | ORAL | 2 MG, ORAL | D | D | |||
| 5944715 | 1010711614 | SS | SOLU-MEDROL | 1 | 31.5 MG | Y | D | ||||
| 5944715 | 1010711682 | C | ACYCLOVIR | 1 | |||||||
| 5944715 | 1010711710 | C | FIRSTCIN (CEFOZOPRAN HYDROCHLORIDE) INJECTION | 2 | |||||||
| 5944715 | 1010711711 | C | CARBENIN (BETAMIPRON, PANIPENEM) | 2 | |||||||
| 5944715 | 1010711712 | C | VANCOMYCIN HYDROCHLORIDE | 1 | |||||||
| 5944715 | 1010711715 | C | METHOTREXATE | 1 | |||||||
| 5944715 | 1010711717 | C | LEUKOPROL (MIRIMOSTIM) | 2 | |||||||
| 5944715 | 1010711719 | C | NEUTROGIN (LENOGRASTIM) | 2 | |||||||
| 5944715 | 1010711720 | C | GAMMAGARD (IMMUNOGLOBULIN) | 2 | |||||||
| 5944715 | 1010711722 | C | FLUDARA | 1 | |||||||
| 5944715 | 1010711725 | C | ENDOXAN (CYCLOPHOSPHAMINE) | 2 | |||||||
| 5944715 | 1010711728 | C | STRONGER NEO MINOPHAGEN C (AMINOACETIC ACID, GLYCYRRHIZIC ACID, CYSTEI | 2 | |||||||
| 5944715 | 1010711782 | C | FRAGMIN | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5944715 | 1010711611 | CORD BLOOD TRANSPLANT THERAPY |
| 5944715 | 1010711612 | CORD BLOOD TRANSPLANT THERAPY |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5944715 | HO |
| 5944715 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 5944715 | ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
| 5944715 | ALANINE AMINOTRANSFERASE INCREASED |
| 5944715 | ASPARTATE AMINOTRANSFERASE INCREASED |
| 5944715 | ENGRAFTMENT SYNDROME |
| 5944715 | HYPERTRIGLYCERIDAEMIA |
| 5944715 | LIVER DISORDER |
| 5944715 | RENAL DISORDER |
| 5944715 | URINARY SEDIMENT ABNORMAL |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 5944715 | FGN |
| 5944715 | HP |
| 5944715 | OTH |
| 5944715 | SDY |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5944715 | 1010673182 | 20070916 | 20071006 | ||
| 5944715 | 1010673182 | 20071007 | 20071015 | ||
| 5944715 | 1010673182 | 20071016 | 20071114 | ||
| 5944715 | 1010711611 | 20070916 | 20071109 | ||
| 5944715 | 1010711612 | 20071110 | |||
| 5944715 | 1010711614 | 20071008 | 20071016 |